meta_pixel
Tapesearch Logo
Log in
Good Morning America

GMA3: Wednesday, December 4

Good Morning America

ABC News

Politics, Entertainment News, Daily News, News

4.81K Ratings

🗓️ 4 December 2024

⏱️ 37 minutes

🧾️ Download transcript

Summary

Mindy Kaling talks new season of 'The Sex Lives of College Girls'; New developments in the JonBenet Ramsey murder case; Cash Warren talks 'Good Fits' initiative to celebrate National Sock Day. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

This is an ad from BetterHelp.

0:02.4

This holiday season, do something for a special person in your life.

0:06.3

You give yourself the gift of better mental health.

0:09.8

BetterHelp online therapy connects you with a qualified therapist via phone, video or live chat.

0:15.1

It's convenient and affordable and can be done from the comfort of your own home.

0:19.1

Having someone to talk to is truly a gift,

0:21.6

especially during the holidays. Visit betterhelp.com to learn more and save 10% of your first month.

0:27.1

That's betterhelp, help.com.

0:31.0

Now from Times Square, here's what you need to know.

0:35.5

Zep bound and we go with weight loss drugs. So this can get confusing because as more products come on the market, more people are asking questions, how do we compare them?

0:43.3

And this is one of those studies which helps us to look at the outcome of weight loss.

0:47.3

So Zepbound has the active ingredient to Zepatide.

0:50.3

Wagovi, the active ingredient, semaglite, that's also in OZempic. In this study, they looked at adults who were using this medication, and they found that Zepbound

0:58.0

had significantly increased amount of weight loss. If you look at these numbers, Zepbound was associated

1:03.0

with a 20% weight loss. That's an approximate 50 pound on average drop.

1:07.0

And Wagovi, 14%, an average 33 pound drop. Now this is consistent with the studies

1:12.9

that we've seen before. One of the reasons are the researchers pointed to this is the mechanism

1:17.5

of action. Zep bound targets two different receptors in our body, whereas somaglotide and

1:22.4

Wagovi targets one receptor. So the questions that many people have is, which one should

1:26.7

I take if they're taking one?

1:28.4

You know, that's the question that I immediately thought of.

1:30.6

How would I help a patient get through these decisions?

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from ABC News, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of ABC News and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.